406 related articles for article (PubMed ID: 22490320)
1. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.
Shapiro JA; Klabunde CN; Thompson TD; Nadel MR; Seeff LC; White A
Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):895-904. PubMed ID: 22490320
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer test use from the 2005 National Health Interview Survey.
Shapiro JA; Seeff LC; Thompson TD; Nadel MR; Klabunde CN; Vernon SW
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1623-30. PubMed ID: 18628413
[TBL] [Abstract][Full Text] [Related]
3. Trends in colorectal cancer test use among vulnerable populations in the United States.
Klabunde CN; Cronin KA; Breen N; Waldron WR; Ambs AH; Nadel MR
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1611-21. PubMed ID: 21653643
[TBL] [Abstract][Full Text] [Related]
4. Utilization Pattern of Computed Tomographic Colonography in the United States: Analysis of the U.S. National Health Interview Survey.
Hong YR; Xie Z; Turner K; Datta S; Bishnoi R; Shah C
Cancer Prev Res (Phila); 2021 Jan; 14(1):113-122. PubMed ID: 32938642
[TBL] [Abstract][Full Text] [Related]
5. Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates.
Ebner DW; Finney Rutten LJ; Miller-Wilson LA; Markwat N; Vahdat V; Ozbay AB; Limburg PJ
Cancer Prev Res (Phila); 2024 Jun; 17(6):275-280. PubMed ID: 38561018
[TBL] [Abstract][Full Text] [Related]
6. Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.
Vanness DJ; Knudsen AB; Lansdorp-Vogelaar I; Rutter CM; Gareen IF; Herman BA; Kuntz KM; Zauber AG; van Ballegooijen M; Feuer EJ; Chen MH; Johnson CD
Radiology; 2011 Nov; 261(2):487-98. PubMed ID: 21813740
[TBL] [Abstract][Full Text] [Related]
7. Insurance Coverage for CT Colonography Screening: Impact on Overall Colorectal Cancer Screening Rates.
Smith MA; Weiss JM; Potvien A; Schumacher JR; Gangnon RE; Kim DH; Weeth-Feinstein LA; Pickhardt PJ
Radiology; 2017 Sep; 284(3):717-724. PubMed ID: 28696184
[TBL] [Abstract][Full Text] [Related]
8. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
[TBL] [Abstract][Full Text] [Related]
9. The impact of CT colonography for colorectal cancer screening on the UK NHS: costs, healthcare resources and health outcomes.
Sweet A; Lee D; Gairy K; Phiri D; Reason T; Lock K
Appl Health Econ Health Policy; 2011; 9(1):51-64. PubMed ID: 21174482
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
11. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
Seeff LC; Shapiro JA; Nadel MR
J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
[TBL] [Abstract][Full Text] [Related]
12. Participation in colorectal cancer screening: a review.
Vernon SW
J Natl Cancer Inst; 1997 Oct; 89(19):1406-22. PubMed ID: 9326910
[TBL] [Abstract][Full Text] [Related]
13. Sociodemographic Factors and Screening CT Colonography Use Among Medicare Beneficiaries.
Christensen EW; Sanelli PC; Rula EY; Chang KJ; Moreno CC; Bruining DH; Yee J
AJR Am J Roentgenol; 2024 Jan; 222(1):e2329703. PubMed ID: 37466190
[No Abstract] [Full Text] [Related]
14. Vital signs: colorectal cancer screening test use--United States, 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(44):881-8. PubMed ID: 24196665
[TBL] [Abstract][Full Text] [Related]
15. Update on Flexible Sigmoidoscopy, Computed Tomographic Colonography, and Capsule Colonoscopy.
Chung SW; Hakim S; Siddiqui S; Cash BD
Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):569-583. PubMed ID: 32439089
[TBL] [Abstract][Full Text] [Related]
16. Trends in colorectal cancer testing among Medicare subpopulations.
Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
[TBL] [Abstract][Full Text] [Related]
17. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
18. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
[TBL] [Abstract][Full Text] [Related]
19. Screening for Colorectal Cancer in the United States: Correlates and Time Trends by Type of Test.
Shapiro JA; Soman AV; Berkowitz Z; Fedewa SA; Sabatino SA; de Moor JS; Clarke TC; Doria-Rose VP; Breslau ES; Jemal A; Nadel MR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1554-1565. PubMed ID: 34088751
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
